Wize Pharma, Inc. | Business Contracts

Employment Agreement by and between Mawson Infrastructure Group Inc. and Rahul Mewawalla, dated May 22, 2023 (Filed With SEC on May 25, 2023)

Letter Deed of Departure by and between Mawson Infrastructure Group Pty Ltd and James Manning, dated May 22, 2023 (Filed With SEC on May 25, 2023)

Form of Common Warrant (Filed With SEC on May 8, 2023)

Form of Pre-Funded Warrant (Filed With SEC on May 8, 2023)

Form of Placement Agent Warrant (Filed With SEC on May 8, 2023)

Form of Warrant Amendment Agreement dated May 3, 2023 (Filed With SEC on May 8, 2023)

Form of Securities Purchase Agreement (Filed With SEC on May 8, 2023)

Description of Securities (Filed With SEC on March 23, 2023)

2021 Equity Incentive Plan (Filed With SEC on March 23, 2023)

Director Appointment Letter between the Company and Rahul Mewawalla dated January 31, 2023 (Filed With SEC on January 31, 2023)

First Amendment to Equipment Purchase and Sale Agreement between Mawson Infrastructure Group Inc. (the Company), Cosmos Infrastructure, LLC, and CleanSpark GLP, LLC, dated October... (Filed With SEC on October 26, 2022)

First Amendment to Purchase and Sale Agreement by and among CSRE Properties Sandersville, LLC, Luna Squares LLC, Mawson Infrastructure Group, Inc. and CleanSpark, Inc., dated... (Filed With SEC on October 11, 2022)

Purchase and Sale Agreement, dated as of September 8, 2022, by and among CSRE Properties Sandersville, LLC, Luna Squares LLC, Mawson Infrastructure Group, Inc. and CleanSpark, Inc (Filed With SEC on September 9, 2022)

Equipment Purchase and Sale Agreement, dated as of September 8, 2022, by and among CleanSpark GLP, LLC, Cosmos Infrastructure, LLC and Mawson Infrastructure Group, Inc (Filed With SEC on September 9, 2022)

Form of Warrant (Filed With SEC on July 19, 2022)

Form of Placement Agent Warrant (Filed With SEC on July 19, 2022)

Form of Securities Purchase Agreement (Filed With SEC on July 19, 2022)

Form of Secured Convertible Promissory Note (Filed With SEC on July 14, 2022)

At The Market Offering Agreement between Mawson Infrastructure Group Inc. and H.C. Wainwright & Co., LLC (Filed With SEC on May 27, 2022)

Description of Securities (Filed With SEC on March 21, 2022)

Warrant Agreement between Mawson Infrastructure Group Inc and Celsius Mining LLC dated February 23, 2022 (Filed With SEC on March 1, 2022)

Securities Purchase Agreement dated August 6, 2021 (Filed With SEC on November 15, 2021)

Electricity Supply Agreement between MIG No.1 Pty Ltd and Cape Byron Management Pty Ltd dated October 22, 2021 (Filed With SEC on October 22, 2021)

Employment Agreement between Mawson Infrastructure Group Pty Ltd and Nicholas Hughes-Jones dated October 8, 2021 (Filed With SEC on October 8, 2021)

Underwriting Agreement, dated September 28, 2021, by and between Mawson Infrastructure Group Inc., and H.C. Wainwright & Co., LLC (Filed With SEC on October 1, 2021)

Form of Warrant Agreement (Filed With SEC on October 1, 2021)

Form of Compensation Warrant (Filed With SEC on October 1, 2021)

Lease Agreement between Mawson Infrastructure Group and Jewel Acquisition, LLC dated September 20, 2021 (Filed With SEC on September 21, 2021)

Second Amendment to Lease Agreement between Luna Squares LLC and The Development Authority of Washington County dated August 24, 2021 (Filed With SEC on August 30, 2021)

Resignation letter of Or Eisenberg (Filed With SEC on August 20, 2021)

Employment Agreement of Hetal Majithia dated August 19, 2021 (Filed With SEC on August 20, 2021)

Employment Agreement between Mawson Infrastructure Group Inc. and Liam Daniel Wilson (Filed With SEC on August 12, 2021)

International Sales Contract No. ZY0220211229 between Mawson Infrastructure Group Pty Ltd and Canaan Convey Co. Ltd (Filed With SEC on August 12, 2021)

Form of Securities Purchase Agreement dated August 6, 2021 (Filed With SEC on August 10, 2021)

Amendment to Convertible Loans Agreements dated November 29, 2019 (Filed With SEC on July 27, 2021)

Amendment to Exclusive Distribution and Licensing Agreement by and between Wize Pharma Ltd., OcuWize Ltd. and Resdevco Research and Development Company Ltd., dated May 4, 2020 (Filed With SEC on July 27, 2021)

Membership Interest Purchase Agreement dated July 5, 2021 between Mawson Infrastructure Group Inc. and Kyle Hoffman (Filed With SEC on July 9, 2021)

Membership Interest Purchase Agreement dated July 6, 2021 between Mawson Infrastructure Group Inc. and TRS Ventures LLC (Filed With SEC on July 9, 2021)

Form of February 2021 Convertible Note (Filed With SEC on June 9, 2021)

Warrant issued to HC Wainwright (Filed With SEC on June 9, 2021)

Warrants issued to W Capital Advisors Pty Limited (Filed With SEC on June 9, 2021)

Lease Agreement between Luna Squares LLC (FKA Innovative Preperty Management, LLC) and The Development Authority of Washington County dated May 1, 2020 (Filed With SEC on May 19, 2021)

First Amendment to Lease Agreement and Exercise of Option to Lease an Additional Four Adjoining Acres between Luna Squares LLC (FKA Innovative Property Management, LLC) and The... (Filed With SEC on May 19, 2021)

International Sales Contract No:ZY0220211061 between Cosmos Infrastructure LLC and Canaan Convey Co., Ltd. dated February 5, 2021 (Filed With SEC on May 19, 2021)

International Sales Contract NoZY0220211163 between Cosmos Infrastructure LLC and Canaan Convey Co., Ltd. dated March 26, 2021 (Filed With SEC on May 19, 2021)

Equipment Purchase and Finance and Security Agreement with Foundry Digital LLC (Filed With SEC on May 19, 2021)

Amendment To The Equipment Finance And Security Agreement Dated February 5, 2021 (Filed With SEC on May 19, 2021)

Second Amendment To The Equipment Finance And Security Agreement Dated April 1, 2021 (Filed With SEC on May 19, 2021)

Description of Securities (Filed With SEC on March 1, 2021)

Amendment to Exclusive Distribution and Licensing Agreement by and between Wize Pharma Ltd., OcuWize Ltd. and Resdevco Research and Development Company Ltd., dated May 4, 2020 (Filed With SEC on March 1, 2021)

Deed of Amendment, dated January 18, 2021, of the Bid Implementation Agreement between Wize Pharma, Inc. and Cosmos Capital Limited, dated December 30, 2020 (Filed With SEC on January 19, 2021)

Form of Stock Restriction Agreement (Filed With SEC on January 19, 2021)

Form of Contingent Value Rights Agreement (Filed With SEC on January 19, 2021)

Bid Implementation Agreement, between Wize Pharma, Inc. and Cosmos Capital Limited, dated December 30, 2020 (Filed With SEC on January 5, 2021)

Form of Warrant Agency Agreement (Filed With SEC on January 5, 2021)

Form of Contingent Value Rights Agreement (Filed With SEC on January 5, 2021)

Form of Securities Purchase Agreement, between Wize Pharma, Inc. and various Purchasers, dated December 30, 2020 (Filed With SEC on January 5, 2021)

Securities Purchase Agreement, between Wize Pharma, Inc. and Noam Danenberg, dated December 30, 2020 (Filed With SEC on January 5, 2021)

Addendum Agreement, between Wize Pharma, Inc. and Bonus BioGroup Ltd., dated November 29, 2020 (Filed With SEC on November 30, 2020)

Form of Amendment No. 1, dated as of October 28, 2020, to the Securities Purchase Agreement of October 22, 2018, by and among the Company and the investors signatory thereto (Filed With SEC on November 16, 2020)

Letter Agreement (SPA), dated June 24, 2020, by and between the Company and Bonus BioGroup Ltd (Filed With SEC on August 14, 2020)

Amendment to Letter Agreement (SPA), dated July 1, 2020, by and between the Company and Bonus BioGroup Ltd (Filed With SEC on August 14, 2020)

Description of Securities (Filed With SEC on March 30, 2020)

Memorandum of Understanding between Wize Pharma Ltd. and Resdevco, Research and Development Ltd. dated February 24, 2019 (Filed With SEC on March 30, 2020)

Exchange Agreement by and between Bonus BioGroup Ltd. and Wize Pharma Inc., dated January 9, 2020 (Filed With SEC on January 15, 2020)

Share Purchase Agreement by and between Bonus BioGroup Ltd. and Wize Pharma Inc., dated January 9, 2020 (Filed With SEC on January 15, 2020)

Form of Registration Rights Agreement (Filed With SEC on January 15, 2020)

Series B Purchase Agreement by and between Wize Pharma Inc. and various investors, dated January 9, 2020 (Filed With SEC on January 15, 2020)

Form of Purchase Agreement (Filed With SEC on December 20, 2019)

Form of Warrant (Filed With SEC on December 20, 2019)

Form of Purchase Agreement (Filed With SEC on December 9, 2019)

Form of Warrant (Filed With SEC on December 9, 2019)

Exclusive License Agreement (the License Agreement) with Copernicus Therapeutics, Inc (Filed With SEC on November 14, 2019)

Amendment to License Agreement with Resdevco Research and Development Company Ltd (Filed With SEC on November 14, 2019)

Amendment to Convertible Loan Agreements (Filed With SEC on June 4, 2019)

Form of Warrant (Filed With SEC on June 4, 2019)

Chairman Agreement between the Company and Mark Sieczkarek dated as of April 23, 2019 (Filed With SEC on April 29, 2019)

Memorandum of Understanding between Wize Pharma Ltd. and Resdevco, Research and Development Ltd. dated February 24, 2019 (Filed With SEC on April 1, 2019)

Amendment to Convertible Loan Agreements (Filed With SEC on March 4, 2019)

Joint Venture Agreement (Filed With SEC on February 12, 2019)

Amendment No. 1 to Consulting Services Agreement (Filed With SEC on November 14, 2018)

Consulting Agreement (Filed With SEC on November 14, 2018)

Purchase Agreement (Filed With SEC on October 23, 2018)

Form of Series A and Series B Warrant (Filed With SEC on October 23, 2018)

Form of Registration Rights Agreement (Filed With SEC on October 23, 2018)

Convertible Loan Amendment (Filed With SEC on October 23, 2018)

Placement Agency Agreement (Filed With SEC on October 23, 2018)

Employment Agreement, dated August 21, 2018, between Wize Pharma Ltd. And Or Eisenberg (Filed With SEC on August 22, 2018)

Consulting Services Agreement, dated August 20, 2018, between Wize Pharma Ltd., N. Danenberg Holdings (2000) Ltd. and Noam Danenberg (Filed With SEC on August 22, 2018)

Amendment to 2018 Equity Incentive Plan (Filed With SEC on August 21, 2018)

Exclusive Distribution Agreement dated May 31, 2018 (Confidential treatment was requested with respect to certain portions of this exhibit pursuant to 17.C.F.R. 240.24b-2. Omitted... (Filed With SEC on June 5, 2018)

Third Amendment to Exclusive Distribution and Licensing Agreement by and between Wize Pharma Ltd. and Resdevco Research and Development Company Ltd., dated December 26, 2017 (Filed With SEC on March 29, 2018)

Memorandum of Understanding by and between Wize Pharma Ltd. and Resdevco Research and Development Company Ltd., dated January 8, 2018 (Filed With SEC on March 29, 2018)

2018 Stock Incentive Plan (Filed With SEC on February 28, 2018)

Specimen Common Stock Certificate (Filed With SEC on February 6, 2018)

Form of PIPE Warrant (Filed With SEC on February 6, 2018)

Letter Amendment to Convertible Loans, dated as of December 21, 2017, by and between Wize Pharma, Inc., Wize Pharma Ltd., Ridge Valley Corporation, Rimon Gold Assets Ltd. and... (Filed With SEC on December 27, 2017)

Letter dated September 6, 2017 from Resdevco Ltd (Filed With SEC on November 21, 2017)

Agreement dated September 25, 2017 between Resdevco Ltd. and Wize Pharma Ltd (Filed With SEC on November 21, 2017)

Amendment No. 1 to Agreement and Plan of Merger, dated as of October 31, 2017, by and among OphthaliX, Inc., Bufiduck Ltd. and Wize Pharma Ltd (Filed With SEC on November 1, 2017)

Exclusive Distribution and Licensing Agreement dated May 1, 2015 between Resdevco Ltd. and Wize Pharma Ltd. (formerly Star Night Technologies Ltd.) (Filed With SEC on July 27, 2017)

Amendment to Licensing Agreement dated November 22, 2015 between Resdevco Ltd. and Wize Pharma Ltd (Filed With SEC on July 27, 2017)

Amendment No. 2 to Licensing Agreement dated March 20, 2016 between Resdevco Ltd. and Wize Pharma Ltd (Filed With SEC on July 27, 2017)

Amendment No. 1 to Licensing Agreement Israeli Market dated May 31, 2016 between Resdevco Ltd. and Wize Pharma Ltd (Filed With SEC on July 27, 2017)

Amendment No. 2 to Licensing Agreement Ukraine Market dated May 31, 2016 between Resdevco Ltd. and Wize Pharma Ltd (Filed With SEC on July 27, 2017)

Addition to Amendment to Licensing Agreement dated January 6, 2017 between Resdevco Ltd. and Wize Pharma Ltd (Filed With SEC on July 27, 2017)

Second Addition to Amendment to Licensing Agreement dated March 30, 2017 between Resdevco Ltd. and Wize Pharma Ltd (Filed With SEC on July 27, 2017)

Correction to Licensing Agreement dated June 16, 2017 between Resdevco Ltd. and Wize Pharma Ltd (Filed With SEC on July 27, 2017)

Appendix F to Exclusive Distribution and Licensing Agreement between Resdevco Ltd. and Wize Pharma Ltd. signed on May 1, 2015 dated July 20, 2017 (Filed With SEC on July 27, 2017)

Appendix G to Exclusive Distribution and Licensing Agreement between Resdevco Ltd. and Wize Pharma Ltd. signed on May 1, 2015 dated July 20, 2017 (Filed With SEC on July 27, 2017)

Assumption Agreement dated August 30, 2016 between Resdevco Ltd. and OcuWize Ltd (Filed With SEC on July 27, 2017)

Convertible Loan Agreement dated March 20, 2016 between Wize Pharma Ltd. and Rimon Gold Assets Ltd. (unofficial English translation from Hebrew) (Filed With SEC on July 27, 2017)

Addendum to Convertible Loan Agreement dated March 30, 2016 between Wize Pharma Ltd. and Rimon Gold Assets Ltd. (unofficial English translation from Hebrew) (Filed With SEC on July 27, 2017)

Second Convertible Loan Agreement dated January 12, 2017 between Wize Pharma Ltd. Ridge Valley Corporation and Rimon Gold Assets Ltd. (unofficial English translation from Hebrew) (Filed With SEC on July 27, 2017)

Debenture Floating Charge dated March 20, 2016 between Wize Pharma Ltd. and Rimon Gold Assets Ltd. (unofficial English translation from Hebrew) (Filed With SEC on July 27, 2017)

Debenture - Fixed Charge dated March 20, 2016 between Wize Pharma Ltd. and Rimon Gold Assets Ltd. (unofficial English translation from Hebrew) (Filed With SEC on July 27, 2017)

Debenture Floating Charge dated October 26, 2016 between Ocu Wize Ltd. and Rimon Gold Assets Ltd. (unofficial English translation from Hebrew) (Filed With SEC on July 27, 2017)

Debenture Fixed Charge dated October 26, 2016 between Ocu Wize Ltd. and Rimon Gold Assets Ltd. (unofficial English translation from Hebrew) (Filed With SEC on July 27, 2017)

Amendment to Debenture Floating Charge dated March 28, 2017 between Wize Pharma Ltd. and Rimon Gold Assets Ltd. (unofficial English translation from Hebrew) (Filed With SEC on July 27, 2017)

Amendment to Debenture Fixed Charge dated March 28, 2017 between Wize Pharma Ltd. and Rimon Gold Assets Ltd. (unofficial English translation from Hebrew) (Filed With SEC on July 27, 2017)

Amendment to Debenture Floating Charge dated March 28, 2017 between Ocu Wize Ltd. and Rimon Gold Assets Ltd. (unofficial English translation from Hebrew) (Filed With SEC on July 27, 2017)

Amendment to Debenture Fixed Charge dated March 28, 2017 between Ocu Wize Ltd. and Rimon Gold Assets Ltd. (unofficial English translation from Hebrew) (Filed With SEC on July 27, 2017)

Form of Irrevocable Guaranty and Undertaking (Filed With SEC on July 27, 2017)

Private Placement Agreement dated May 25,2017 between Wize Pharma Ltd. and Jonathan Brian Rubini (Filed With SEC on July 27, 2017)

Addendum to Private Placement Agreement dated June 15, 2017 between Wize Pharma Ltd. and Jonathan Brian Rubini (Filed With SEC on July 27, 2017)

Private Placement Agreement dated June 23, 2017 between Wize Pharma Ltd. and Simcha Sadan (Filed With SEC on July 27, 2017)

Private Placement Agreement dated June 23, 2017 between Wize Pharma Ltd. and Yaacov Zrachia (Filed With SEC on July 27, 2017)

Private Placement Agreement dated June 23, 2017 between Wize Pharma Ltd. and Peretz Yosef Eliahu (Filed With SEC on July 27, 2017)

Employment Agreement dated September 30, 2015 between Wize Pharma Ltd. and Or Eisenberg (unofficial English translation from Hebrew) (Filed With SEC on July 27, 2017)

Agreement for Provision of Services Agreement dated September 30, 2015 between Wize Pharma Ltd. and N Danenberg Holdings (2000) Ltd. (unofficial English translation from Hebrew) (Filed With SEC on July 27, 2017)

Agreement for Provision of Services Agreement dated September 30, 2015 between Wize Pharma Ltd. and Ron Mayron (unofficial English translation from Hebrew) (Filed With SEC on July 27, 2017)

Finders Agreement dated June 19, 2017 between Wize Pharma Ltd. and Harbin Israel (Trading) Ltd (Filed With SEC on July 27, 2017)

Agreement and Plan of Merger, dated as of May 21, 2017, by and among OphthaliX, Inc., Bufiduck Ltd. and Wize Pharma Ltd (Filed With SEC on May 22, 2017)

Voting and Undertaking Agreement, dated as of May 21, 2017, by and among OphthaliX, Inc., Wize Pharma Ltd., and Can-Fite BioPharma Ltd (Filed With SEC on May 22, 2017)

Form of Stock Purchase Agreement (Filed With SEC on May 22, 2017)

Form of Termination of License Agreement (Filed With SEC on May 22, 2017)

Form of Termination of Services Agreement (Filed With SEC on May 22, 2017)

AMENDMENTTO SHARE PURCHASE AGREEMENT (Filed With SEC on August 27, 2015)

SHAREPURCHASE AGREEMENT (Filed With SEC on June 19, 2015)

Made as of the 1 day of July, 2013 (Filed With SEC on March 27, 2014)

OphthaliXInc. STOCK OPTION AGREEMENT FORM (Filed With SEC on July 2, 2013)

Made as of the 28 day of April, 2013 (Filed With SEC on July 2, 2013)

EXHIBIT B TERMS OF THE OPTION (Filed With SEC on July 2, 2013)

Made as of the 1 day ofJuly, 2013 (Filed With SEC on July 2, 2013)

OPHTHALIX INC. (Filed With SEC on July 2, 2013)

Exhibit 2.1 AGREEMENT AND PLAN OF MERGER BETWEEN OPHTHALIX INC. A NEVADA CORPORATION AND OPHTHALIX INC. A DELAWARE CORPORATION (Filed With SEC on April 5, 2012)

Exhibit 4.1 (Filed With SEC on March 30, 2012)

Exhibit 10.6 (Filed With SEC on March 30, 2012)

Exhibit 10.7 (Filed With SEC on March 30, 2012)

Exhibit 10.8 (Filed With SEC on March 30, 2012)

Exhibit 4.1 OPHTHALIX INC. 2012 STOCK INCENTIVE PLAN (Filed With SEC on February 9, 2012)

AGREEMENT (Filed With SEC on November 23, 2011)

WARRANT TO PURCHASE COMMON STOCK OF DENALI CONCRETE MANAGEMENT, INC. (Filed With SEC on November 23, 2011)

DENALI CONCRETE MANAGEMENT, INC. STOCK PURCHASE AGREEMENT (Filed With SEC on November 23, 2011)

LICENSE AGREEMENT (Filed With SEC on November 23, 2011)

SERVICES AGREEMENT (Filed With SEC on November 23, 2011)

Exhibit 2.1 (Filed With SEC on November 14, 2011)

Exhibit 2.2 (Filed With SEC on November 14, 2011)

Exhibit 2.3 (Filed With SEC on November 14, 2011)

AMENDMENTNO. 1 TO THE LETTER OF INTENT (Filed With SEC on September 16, 2008)

Denali Concrete Management, Inc. (Filed With SEC on July 23, 2008)

Wize Pharma, Inc. (161)